Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation CRISPR gene editing platform to create potential one-time curative therapies, today announced new ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

The UK is poised to lead the next great leap in agriculture, with gene-editing technology offering a lifeline to a ...

MGX’s gene editing uses metagenomics and AI to build ... So far, MGX’s tools include nucleases, base editors, and CRISPR transposases that could help with hemophilia A. It’s also possible ...

CRISPR Therapeutics is a mid-stage biotech specializing in gene editing. It became the first gene-editing treatment that uses the Nobel Prize-winning CRISPR technique, an impressive achievement by ...

Key players make use of innovation for growth based on emergent trends, including CRISPR gene editing and high-throughput screening. Key challenges include poor complex human physiological ...

The Exa-cel gene therapy treatment is at the forefront of medical technology. It takes the person’s DNA and “edits” out the faulty sickle gene. It’s expensive, too. According to the manufacturer, ...

Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking ...

an innovative product designed to revolutionize the field of CRISPR gene editing. By leveraging a groundbreaking guide RNA (gRNA) design strategy, XDel technology ensures robust, reliable, and ...

That view was echoed by Intellia's chief executive, John Leonard, who said the data "underscore[s] the tremendous potential of [the] in vivo CRISPR gene editing therapy" and "sets NTLA-2002 apart ...

Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company with a market capitalization of $113.7 billion, is navigating a critical juncture as it seeks to expand its therapeutic reach and ...